Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. ProShares UltraShort MidCap400 Industry Stock Comparison

Sell
37

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
14.28
Seasonality Move:
-4.75%
Sell
44

MZZ
ProShares UltraShort MidCap400

Last Price:
10.38
Seasonality Move:
-7.04%
Sell
37
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.29. The Score for BIS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
ProShares UltraShort MidCap400 (MZZ) is a Sell

Is ProShares UltraShort MidCap400 a Buy, Sell or Hold?

  • The current ProShares UltraShort MidCap400 [MZZ] share price is $10.38. The Score for MZZ is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • MZZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $14.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

MZZ Stock Price Chart

What is ProShares UltraShort MidCap400's stock price today?

  • The ProShares UltraShort MidCap400 share price today is $10.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MZZ is experiencing slight selling pressure.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 39.26 Sell
Chaikin Money Flow: 70960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.39 - 15.09) Sell
Bollinger Bands (100): (14.76 - 17.62) Sell

MZZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 40.92 Sell
Chaikin Money Flow: 105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.63 Sell
20-day SMA: 14.72 Sell
50-day SMA: 14.95 Sell
200-day SMA: 17.35 Sell
8-day EMA: 14.59 Sell
20-day EMA: 14.77 Sell
50-day EMA: 15.21 Sell
200-day EMA: 17.3 Sell

MZZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.83 Sell
20-day SMA: 10.68 Sell
50-day SMA: 10.8 Sell
200-day SMA: 11.69 Sell
8-day EMA: 10.66 Sell
20-day EMA: 10.76 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.91 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares UltraShort MidCap400 Earnings Growth & MZZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProShares UltraShort MidCap400 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):